Incoming Mobility Program

There are no open calls at the moment.

Who is eligible to apply?

Any experienced researcher with a doctoral degree and working at a non-Spanish research organization for at least 24 months at the moment of the call publication is eligible to apply for a fellowship from the CIBERDEM Incoming Mobility Programme (CIMP) to take trans-national placements at the research centers members of the CIBERDEM consortium.

How can you apply?

Candidates to the CIMP fellowships must fill the application form with:

  • Their personal data
  • A letter of motivation
  • A Personal Research Proposal of the project that they plan to develop (max. 3 pages)
  • Their 2 preferred CIBERDEM host institutions from the table below
  • An updated Curriculum Vitae
  • A Reference Letter of a senior member of their current institution

Complete applications will be evaluated by the Selection Committee. All applicants will receive notification of the outcome of their evaluations individually by email. Final results will be published in this website and the selected candidates will be interviewed before the final decision is made. This will take place within two months after the deadline for each call.

How may you prepare your Personal Research Proposal?

Fellow applicants may propose any research project dealing with Diabetes and fitting the major working areas covered by CIBERDEM.

The current call of CIMP fellowships is open to all the consortium research groups with a vacancy on their research labs. In the next table, the applicants can find, as an orientation, the descriptions of several projects to be developed in the different research groups. The applicants may use these as a guide to prepare their Personal Research Proposal.

Lipid Signaling In Diabetes And Obesity.

Prof. Jesús Balsinde Rodríguez, Instituto de Biología y Genética Molecular, Valladolid, Consejo Superior de Investigaciones Científicas.

Más información

Hepatic Insulin Resistance And Beta Cell Plasticity.

Prof. Manuel R. Benito de las Heras, Departamento de Bioquímica y Biología Molecular II, Facultad de Farmacia, Universidad Complutense de Madrid.

Más información

Role of Mitophagy on Mitochondrial Function, Metabolic Homeostasis, and Insulin Sensitivity.

Prof. Antonio Zorzano Olarte, Fundació Privada Institut de Recerca Biomèdica, Barcelona.

Más información

HDL Functionality In Diabetes Mellitus: Studies In Patients And Animal Models.

Prof. Francisco Blanco Vaca, Servei de Bioquímica, Hospital Santa Creu I Sant Pau, Barcelona.

Más información

Transgenic animal models and gene therapy approaches for diabetes.

Prof. Fàtima Bosch, Centre de Biotecnologia Animal i Teràpia Gènica (CBATEG), Universitat Autònoma de Barcelona.

Más información

Metabolomics In Diabetes And Associated Metabolic Desorders.

Prof. Xavier Correig Blanchar, Universitat Rovira I Virgili, Tarragona.

Más información

Pathophysiology of PCOS Related to Environmental Factors.

Prof. Héctor F. Escobar Morreale, Hospital Universitario Ramón y Cajal, Madrid.

Más información

Mechanisms of control of glucose and fatty acid metabolism in skeletal muscle cells and metabolic impairment in atrophy.

Dra. Ana M. Gómez Foix, Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona.

Más información

Hypothalamic regulation of energy homeostasis and glucose metabolism.

Prof. Ramon Gomis, Pancreatic islets: biomarkers and function, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Esther Koplowitz Center, Barcelona.

Más información

Glycogen-induced degeneration associated to diabetic complications.

Prof. Joan J. Guinovart Cirera, Fundació Privada Institut de Recerca Biomèdica, Barcelona.

Más información

Genetics And Epigenetics Of Diabetic Cardiovascular Complications.

Prof. Lluís Masana Marín, Institut d’Investigació Sanitaria Pere Virgili, Hospital Universitari Sant Joan, Reus.

Más información

Islet Cell Regeneration And Cell Therapy In Diabetes Treatment.

Prof. Eduard Montanya, Servei d’Endocrinologia i Nutrició, Hospital Universitari Bellvitge, Barcelona.

Más información

Role Of Leptin And Ghrelin In Alpha And Beta-Cell Function.

Prof. Ángel Nadal, Instituto de Bioingeniería, Universidad Miguel Hernández, Elche.

Más información

microRNAs as mediators of stress responses in β-cells and as biomarkers for type 2 diabetes.

Dr. Anna Novials, Metabolic and Molecular Disturbances in Diabetes, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona.

Más información

Interaction gen-gen-enviromment.

Prof. Federico J. C-Soriguer Escofet, Servicio de Endocrinología y Nutrición. Hospital Universitario Carlos Haya, Málaga.

Más información

Transcriptional Regulation of Glucose Homeostasis.

Prof. Mario Vallejo, Instituto de Investigaciones Biomédicas Alberto Sols, Universidad Autónoma de Madrid, Consejo Superior de Investigaciones Científicas.

Más información

PPAR-δ, inflammation and insulin resitance.

Dr. Manuel Vázquez Carrera, Pharmacology Unit, Department of Pharmacology, University of Barcelona, Barcelona.

Más información

Adipose tissue dynamics in the setting of obesity and insulin resistnace-related diseases.

Dr. Joan J. Vendrell Ortega, Endocrinology and Nutrition, Hospital Universitari Joan XXIII (School of Medicine), Institut d'Investigació Sanitària Pere Virgili (IISPV).

Más información

Further information on research areas of interest and ongoing research projects can be found in the Annual Reports of the CIBERDEM consortium and through the Scientific Articles published by our members.

Which are the CIMP Fellowship conditions?

  • Duration of two years
  • Gross year salary of 31.367,02 €
  • Mobility allowance (6000 to 9600 €/year)
  • Travel allowance (500 to 1500 €/year)
  • And research costs up to 7200€

Fellow CIMP researchers will be employed by CIBERDEM under a contract basis, with 40 hours of work per week (excluding lunch time), 22 days of annual leave (plus statutory days), healthcare coverage provided by the Spanish Social Security system and a Private Accident Insurance.

Please note that all the candidates must either be in possession of a doctoral degree or have at least 4 years of full-time equivalent research experience at the corresponding deadline for submission of proposals.

How will candidates be evaluated?

Eligible applications will be forwarded to the Selection Committee, which will be integrated by the Scientific Director of CIBERDEM, several members of the International Scientific Committee of CIBERDEM and several other experts external to CIBERDEM, experienced in the diabetes field. Each application will be reviewed by two members of this committee, and the final score will be obtained by consensus. If any evaluator has a potential conflict of interests with an applicant, another member of the Selection Committee will take care of the corresponding evaluation.

The evaluators will score the applications according to the following criteria:

  • Scientific & Technological Quality (25p)
  • Potencial impact and transferability (5p)
  • Value for CIBERDEM (5p)
  • CV of the applicant (15p)
  • Track record of the applicant and additional skills (5p)
  • Adequacy of the candidate and the project (5p)

Aplicants with a score under 50 will not pass to the interviewing phase.

The best-scored applicants will be invited to a 30-40 min. interview with two members of the Seleccion Committee, differents to those who evaluated the applicant. The evaluators will score the interview according to the following criteria:

  • Scientific excellence (15p)
  • Scope and clarity of the presentation of the Personal Research Proposal (10p)
  • Potential to become a Top European Researcher (10p)
  • And additional skills (5p)

Only applicants with an added score over 80 will be considered.

Successful applicants will be chosen by the Selection Committee based on the final score obtained (90%) and the strategic needs of the CIBERDEM consortium (10%). The final ranked list will be published afterwards, and applicants will be contacted with detailed information regarding their selection process.